Neuron23 Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess NEU-627 in Healthy Participants (NCT06900751) | Neuron23 Inc. | 2025-06-02 |
| A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease (NCT06680830) | Neuron23 Inc. | 2025-01-17 |
| A Study to Assess NEU-111 in Healthy Participants (NCT06500442) | Neuron23 Inc. | 2024-09-17 |
| A Study to Assess NEU-411 in Healthy Participants (NCT05755191) | Neuron23 Inc. | 2023-05-13 |
| A Study to Assess NEU-723 in Healthy Participants (NCT05633745) | Neuron23 Inc. | 2023-01-30 |
| A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease (NCT04893083) | Neuron23 Inc. | 2021-06-28 |
Track Neuron23 Inc. automatically
Every clearance here is in the API, with alerts when new ones post.